X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12) 12
hematology (10) 10
humans (9) 9
aged (6) 6
middle aged (6) 6
female (5) 5
leukemia (5) 5
lymphomas (5) 5
male (5) 5
adult (4) 4
mutation (4) 4
patients (4) 4
remission induction (4) 4
rituximab (4) 4
survival (4) 4
therapy (4) 4
abridged index medicus (3) 3
aged, 80 and over (3) 3
chemotherapy (3) 3
chronic lymphatic leukemia (3) 3
clinical trials (3) 3
disease (3) 3
lymphocytes b (3) 3
lymphoma (3) 3
medicine, general & internal (3) 3
oncology (3) 3
treatment outcome (3) 3
activation (2) 2
analysis (2) 2
antibodies, monoclonal, murine-derived (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
article (2) 2
b-cell lymphoma (2) 2
care and treatment (2) 2
chop (2) 2
cll (2) 2
comorbidity (2) 2
cryoglobulinemia - drug therapy (2) 2
data collection (2) 2
disease-free survival (2) 2
drug resistance, neoplasm (2) 2
drug therapy (2) 2
elderly-patients (2) 2
follow-up studies (2) 2
gene expression (2) 2
gene mutations (2) 2
hemic and lymphatic diseases (2) 2
herpes zoster (2) 2
international workshop (2) 2
leukemia, lymphocytic, chronic, b-cell - drug therapy (2) 2
leukemia, lymphocytic, chronic, b-cell - genetics (2) 2
leukemia, lymphocytic, chronic, b-cell - metabolism (2) 2
lymphatic leukemia (2) 2
lymphoma, non-hodgkin - drug therapy (2) 2
non-hodgkin-lymphoma (2) 2
quality of life (2) 2
recurrence (2) 2
research (2) 2
vaccination (2) 2
vidarabine - analogs & derivatives (2) 2
1-phosphatidylinositol 3-kinase (1) 1
3' untranslated regions - genetics (1) 1
304 (1) 1
administration, oral (1) 1
adrenal cortex hormones - administration & dosage (1) 1
adult patients (1) 1
adults (1) 1
age factors (1) 1
age of onset (1) 1
aged patients (1) 1
anaplastic large-cell lymphoma (1) 1
anemia, hemolytic, autoimmune - diagnosis (1) 1
anemia, hemolytic, autoimmune - etiology (1) 1
anemia, hemolytic, autoimmune - mortality (1) 1
anemia, hemolytic, autoimmune - therapy (1) 1
anthracyclines (1) 1
antibodies (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - pharmacology (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antigens, cd20 - metabolism (1) 1
antimetabolites, antineoplastic - adverse effects (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antineoplastic agents (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
apoptosis (1) 1
arthralgia (1) 1
arthralgia - chemically induced (1) 1
arthritis (1) 1
atrial fibrillation (1) 1
autografts (1) 1
autoimmune hemolytic-anemia (1) 1
autologous hematopoietic stem cell transplant (1) 1
b-cell receptor (1) 1
b-cell-receptor (1) 1
b-lymphocytes - drug effects (1) 1
b-lymphocytes - immunology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9700, pp. 1512 - 1520
Summary Background Chemotherapy with high-dose methotrexate is the conventional approach to treat primary CNS lymphomas, but superiority of polychemotherapy... 
Internal Medicine | DEFERRED RADIOTHERAPY | MEDICINE, GENERAL & INTERNAL | B-CELL LYMPHOMA | INTERNATIONAL WORKSHOP | RESPONSE CRITERIA | EUROPEAN ORGANIZATION | CONSOLIDATING RADIOTHERAPY | NON-HODGKINS-LYMPHOMA | INITIAL TREATMENT | CENTRAL-NERVOUS-SYSTEM | CEREBROSPINAL-FLUID | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Lymphoma, Non-Hodgkin - radiotherapy | Cranial Irradiation - methods | Central Nervous System Neoplasms - radiotherapy | Adult | Lymphoma, Non-Hodgkin - drug therapy | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Combined Modality Therapy | Remission Induction | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Cytarabine | Patient outcomes | Central nervous system diseases | Dosage and administration | Lymphomas | Drug therapy, Combination | Methotrexate | Drug therapy | Data analysis | Disease | Monoclonal antibodies | Data collection | Radiation therapy | Patients | Tropical diseases | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
by Dagnew, Alemnew F and Ilhan, Osman and Lee, Jae Hoon and Lee, Dong-Gun and Lee, Won-Sik and Lee, Je-Jung and Woszczyk, Dariusz and Kwak, Jae-Yong and Bowcock, Stella and Sohn, Sang Kyun and Rodriguez Macías, Gabriela and Chiou, Tzeon-Jye and Quiel, Dimas and Aoun, Mickael and Navarro Matilla, Maria Belen and de la Serna, Javier and Milliken, Samuel and Murphy, John and McNeil, Shelly A and Salaun, Bruno and Di Paolo, Emmanuel and Campora, Laura and López-Fauqued, Marta and El Idrissi, Mohamed and Schuind, Anne and Heineman, Thomas C and Van den Steen, Peter and Oostvogels, Lidia and Acar, Kadir and Afanasyev, Boris and Alonso Alonso, Aránzazu and Anttila, Veli-Jukka and Barba Suñol, Pere and Blesing, Norbert and Comeau, Terrance and del Campo, Teresa and Disperati, Patricia and Eek, Richard and Eom, HyeonSeok and Gaidano, Gianluca and Grosicki, Sebastian and Guillaume, Thierry and Homenda, Wojciech and Hwang, William and Ilyin, Nikolay and Johnston, Anna and Kim, Seok Jin and Kuo, Ching-Yuan and Kuvshinov, Aleksey and Lepretre, Stephane and Lie, Albert Kwok-Wai and Lucchesi, Alessandro and Masood, Ahmed and Mir, Naheed and Miranda Castillo, Anna Carolina and Mullane, Kathleen and Myasnikov, Alexandr and Oña Navarrete, Raquel and Pauksens, Karlis and Peniket, Andrew and Perez de Oteyza, Jaime and Pohlreich, David and Pullon, Humphrey and Quittet, Philippe and Rodon, Philippe and Rombo, Lars and Samoylova, Olga and Sanmartin Berglund, Johan and Schattner, Ariah and Selleslag, Dominik and Sinisalo, Marjatta and Sultan, Faisal and Theunissen, Koen and Turner, Paul and Wang, Po-Nan and Yáñez San Segundo, Lucrecia and Young, Jo-Anne and Zachee, Pierre and Zaja, Francesco and Zoster-039 Study Grp and Zoster-039 study group
The Lancet Infectious Diseases, ISSN 1473-3099, 09/2019, Volume 19, Issue 9, pp. 988 - 1000
Journal Article
American Journal of Hematology, ISSN 0361-8609, 06/2019, Volume 94, Issue 6, pp. 628 - 634
The histological diagnosis of peripheral T‐cell lymphoma (PTCL) can represent a challenge, particularly in the case of closely related entities such as... 
ORIGIN | RECOGNITION | SIGNATURES | CLONAL HEMATOPOIESIS | CLASSIFICATION | GENE-EXPRESSION ANALYSIS | IDENTIFICATION | HEMATOLOGY | RHOA | PROGNOSTICATION | TOOL
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2015, Volume 373, Issue 18, pp. 1733 - 1747
Journal Article
Blood, ISSN 0006-4971, 2009, Volume 114, Issue 15, pp. 3167 - 3172
Evans syndrome (ES) is a rare disease characterized by the simultaneous or sequential development of autoimmune hemolytic anemia (AIHA) and immune... 
IDIOPATHIC THROMBOCYTOPENIC PURPURA | CRITERIA | SYSTEMIC-LUPUS-ERYTHEMATOSUS | HEMATOLOGICAL DISORDERS | LYMPHOPROLIFERATIVE SYNDROME ALPS | EFFICACY | RITUXIMAB | AUTOIMMUNE HEMOLYTIC-ANEMIA | HEMATOLOGY | MYCOPHENOLATE-MOFETIL | T-CELLS | Lupus Erythematosus, Systemic - complications | Age Factors | Follow-Up Studies | Humans | Middle Aged | Lymphoproliferative Disorders - complications | Male | Data Collection | Lupus Erythematosus, Systemic - mortality | Antineoplastic Agents - administration & dosage | Lupus Erythematosus, Systemic - therapy | Lymphoproliferative Disorders - therapy | Splenectomy - methods | Neutropenia - etiology | Purpura, Thrombocytopenic, Idiopathic - etiology | Purpura, Thrombocytopenic, Idiopathic - therapy | Neutropenia - diagnosis | Anemia, Hemolytic, Autoimmune - therapy | Neutropenia - mortality | Aged, 80 and over | Anemia, Hemolytic, Autoimmune - mortality | Neutropenia - pathology | Anemia, Hemolytic, Autoimmune - diagnosis | Female | Retrospective Studies | Anemia, Hemolytic, Autoimmune - etiology | Antibodies, Monoclonal, Murine-Derived | Risk Factors | Rituximab | Survival Rate | Purpura, Thrombocytopenic, Idiopathic - mortality | Remission Induction | Syndrome | Lupus Erythematosus, Systemic - diagnosis | Disease-Free Survival | Lymphoproliferative Disorders - mortality | Lymphoproliferative Disorders - diagnosis | Purpura, Thrombocytopenic, Idiopathic - diagnosis | Antibodies, Monoclonal - administration & dosage | Age of Onset | Neutropenia - therapy | Aged | Adrenal Cortex Hormones - administration & dosage
Journal Article
Journal Article
Journal Article
Journal Article